A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
Colorectal Cancer (CRC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Study leads
Tao Zhang, MD
Principal Investigator
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology